[E-Daily Reporter Kim Kyung-eun ] Com2uS Corporation(078340)is trading higher in early trading on the 2nd following the initial success of its new massively multiplayer online role-playing game (MMORPG), “ZEUS CO., LTD.: God of Arrogance.”
Official image of ‘ZEUS CO., LTD.: God of Arrogance’. (Photo courtesy of Com2uS Corporation)
According to MP Doctor, as of 9:15 a.m. today, Com2uS Corporation is trading at 38,300 won, up 3,800 won (11.01%) from the previous trading day.
This is interpreted as the new game’s early success stimulating investor sentiment. Since its launch on the 26th of last month, “ZEUS CO., LTD.: God of Arrogance” reached the No. 1 spot in revenue on both Google Play and the App Store within 18 hours and has maintained that position ever since. Given that it typically takes about a week for a new game to reach the No. 1 spot on both platforms, this is considered an exceptional achievement.
The securities industry is also offering positive assessments. KIWOOM Securities raised Com2uS Corporation’s target price from 47,000 won to 50,000 won today.
Kim Jin-gu, an analyst at KIWOOM Securities, explained, “We maintained next year’s forecast—which reflects the normalized performance of ‘Zeus: God of Arrogance,’ a major new release—as the valuation reference point.”
KIWOOM Securities projected the average daily revenue for ZEUS CO., LTD. in the initial quarter to be 1.5 billion won, based on the third quarter of this year. It also normalized the average daily revenue estimates for this year and next year to 960 million won and 470 million won, respectively, and incorporated these figures into its projections.
Analyst Kim “From a medium-term business model perspective, it is somewhat difficult to assess the game as having a ‘mild’ trend in line with initial expectations, given issues such as player-versus-player (PvP) balance,” he added. “We believe the game’s sustainability in terms of user traffic and revenue will be determined by how effectively it addresses its business model and manages small-to-medium-spending users.”
SamsungElectronics will showcase its “AI Living” experience—which connects TVs, home appliances, and mobile devices to support everything from leisure and household chores to health management—at “IFA…
MetaImmuneTech, a company specializing in digital immune cell analysis platforms, has partnered with Vaxcell-Bio Therapeutics(323990), a developer of anti-cancer immunotherapies, to begin actively pio…
Inventage Lab Inc.(389470)The company has begun technical validation of its next-generation subcutaneous (SC) formulation modification platform, “IVL-BioFluidic™.” It has signed Material Transfer Agre…